Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALA + LED photodynamic therapy in moderate to severe acne vulgaris
CTR20190540Phase 2Completed
- Sponsor
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 5-aminolevulinic acid in acne vulgaris, sponsored by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.. Started Jun 2019; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20190540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190540.